Four regenerative peptides, one powerful blend Each peptide in the Klow formulation was selected for a specific role and together they work synergistically to support cellular renewal, healing, and skin radiance
The dose increases systematically over 16-20 weeks until reaching the maintenance dose of 2.4mg weekly
Do not increase your dose unless your healthcare provider recommends it
However, DPP-4 inhibitors (such as sitagliptin or linagliptin) should be discontinued when initiating semaglutide, as both drug classes work through incretin pathways, and combined use offers no additional glycemic benefit while potentially increasing adverse effects
Wegovy: New clinical trial says this weight-loss medication sheds more pounds Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team